JP Morgan Chase
BCAB

JP Morgan Chase’s BIOATLA INC BCAB Stock Holding History

JP Morgan Chase’s Portfolio BCAB Stock Details BCAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$464 Buy
121
+118
+3,933% +$500 ﹤0.01% 7430
2026
Q1 		$20 Hold
3
– – ﹤0.01% 7408
2025
Q4 		$73 Sell
3
-20
-87% -$784 ﹤0.01% 7236
2025
Q3 		$777 Hold
23
– – ﹤0.01% 7011
2025
Q2 		$447 Sell
23
-3
-12% -$61 ﹤0.01% 6707
2025
Q1 		$443 Buy
26
+3
+13% +$64 ﹤0.01% 6716
2024
Q4 		$667 Hold
23
– – ﹤0.01% 6773
2024
Q3 		$1.99K Sell
23
-144
-86% -$12.1K ﹤0.01% 6623
2024
Q2 		$11.4K Sell
167
-444
-73% -$52.8K ﹤0.01% 6233
2024
Q1 		$105K Sell
611
-169
-22% -$21K ﹤0.01% 5650
2023
Q4 		$95.9K Sell
780
-131
-14% -$11.4K ﹤0.01% 5750
2023
Q3 		$77.4K Buy
911
+4
+0.4% +$510 ﹤0.01% 5630
2023
Q2 		$136K Buy
907
+706
+351% +$121K ﹤0.01% 5307
2023
Q1 		$27K Sell
201
-3,115
-94% -$561K ﹤0.01% 5896
2022
Q4 		$1.37M Sell
3,316
-2,248
-40% -$933K ﹤0.01% 3848
2022
Q3 		$2.14M Buy
5,564
+67
+1% +$21.9K ﹤0.01% 3408
2022
Q2 		$783K Buy
5,497
+5,172
+1,591% +$823K ﹤0.01% 4263
2022
Q1 		$81K Buy
325
+25
+8% +$10.5K ﹤0.01% 5600
2021
Q4 		$295K Sell
300
-230
-43% -$294K ﹤0.01% 5141
2021
Q3 		$780K Buy
530
+362
+215% +$705K ﹤0.01% 4474
2021
Q2 		$356K Sell
168
-1,434
-90% -$3.24M ﹤0.01% 4911
2021
Q1 		$4.07M Buy
1,602
+1,580
+7,182% +$4.05M ﹤0.01% 3147
2020
Q4 		$37K Buy
+22
New +$36.8K ﹤0.01% 5214

Other funds holding BCAB

ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Lido Advisors
Lido Advisors Los Angeles, California $36.8B AUM 26.6% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

JP Morgan Chase's BCAB Position: Q2 2026 in Review

JP Morgan Chase increased its BIOATLA INC (BCAB) stake by 3,933% in Q2 2026, buying an estimated $500 and bringing the position to 121 shares worth $464. The position accounts for ﹤0.01% of the portfolio, ranked #7430.

JP Morgan Chase first reported a position in BCAB in Q4 2020 and has held it in 23 quarters since. The position peaked at $4.07M in Q1 2021. 21 funds tracked by Wall St. Rank hold BCAB as of Q2 2026.

  • JP Morgan Chase held 121 shares of BIOATLA INC worth $464 as of Q2 2026.
  • JP Morgan Chase bought 118 BIOATLA INC shares in Q2 2026, an estimated $500.
  • BIOATLA INC made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #7430 holding.
  • JP Morgan Chase first reported a position in BIOATLA INC in Q4 2020 and has held it in 23 quarters since.
  • JP Morgan Chase's BIOATLA INC position peaked at $4.07M in Q1 2021.
  • 21 funds tracked by Wall St. Rank held BIOATLA INC as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.